Zydus granted Orphan Drug Designation by the USFDA for Saroglitazar in the treatment of patients with Primary Biliary Cholangitis (PBC) admin Thu, 01/28/2021 - 16:23
source https://www.pharmatutor.org/pharma-news/2021/zydus-granted-orphan-drug-designation-by-the-usfda-for-saroglitazar-in-the-treatment-of-patients-with-primary-biliary-cholangitis
Subscribe to:
Post Comments (Atom)
-
Results from a clinical trial published in 2011 confirmed the benefit of using Avastin over laser therapy for treating the most severe c...
-
The National Institutes of Health announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19...
-
Cipla and Dr Reddys Lab receives FDA nod for Cancer medicine Cipla and Dr Reddys Lab receives FDA nod for marketing of generic version of...
No comments:
Post a Comment